1. Value of Information and Pricing New Healthcare Interventions

   • Andrew R. Willan
   • Simon Eckermann

   Leading Article 23 December 2012 Pages: 447 - 459

   

2. A Critical Review of Model-Based Economic Studies of Depression

   • Hossein Haji Ali Afzali
   • Jonathan Karnon
   • Jodi Gray

   Review Article 23 December 2012 Pages: 461 - 482

   

3. Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura

   • Dwayne Boyers
   • Xueli Jia
   • Graham Mowatt

   Review Article 23 December 2012 Pages: 483 - 495

   

4. Pharmacoeconomics of the Myeloid Growth Factors

   • Bradford R. Hirsch
   • Gary H. Lyman

   Systematic Review 23 December 2012 Pages: 497 - 511

   

5. Cost Effectiveness of Quetiapine in Patients with Acute Bipolar Depression and in Maintenance Treatment after an Acute Depressive Episode

   • Mattias Ekman
   • Peter Lindgren
   • Mary Lou Chatterton

   Original Research Article 23 December 2012 Pages: 513 - 530

   

6. The Lack of Impact of Quality-of-Life Measures in Schizophrenia: A Shared Responsibility?

   • Laurent Boyer
   • Pascal Auquier

   Correspondence 23 December 2012 Pages: 531 - 532

7. The Authors’ Reply

   • A. George Awad
   • Lakshmi N. P. Voruganti

   Correspondence 23 December 2012 Pages: 532 - 533

8. Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study

   • Laura T. Pizzi
   • Amy Talati
   • Peter K. Sand

   Erratum 23 December 2012 Pages: 534 - 535